Billionaires Holding *PF*

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 23.9M
    Shares Outstanding

  • 291.1M
    Market Cap

News & Insights

ABOUT

*PF*

Celladon Corporation, a clinical-stage biotechnology company, focuses on developing cardiovascular gene therapy and calcium dysregulation. The company’s lead product candidate includes MYDICAR that uses genetic enzyme replacement therapy to correct the Sarco/endoplasmic reticulum Ca 2+ -ATPase 2a...

Here’s Buffett’s Most Recent Acquisition

NEWS

Herbalife: Carl Icahn Comes Out On Top

READ MORE